Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome (NECTAR)

University Hospital Bonn (UKB)

Status: Enrolling

Conditions: Kidney Failure, Acute

Study type: Observational

Funder types: Other

Identifiers

NCT04446858

NECTAR

Details and patient eligibility

About

Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic portosystemic shunt (TIPS). Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

Full description

NECTAR consists of patients with ACLF and renal failure with and without receiving transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Internal Medicine I, University of Bonn, Germany and receiving a structured routine evaluation and follow up program. The diagnosis of cirrhosis was based on clinical, hemodynamic and biochemical parameters, and ultrasound and/or biopsy criteria.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with portal hypertension and kidney failure

Exclusion criteria

• no consent, no kidney failure, no portal hypertension

Trial design

1,000 participants in 2 patient groups

With TIPS

Description:

Prospective cohort that received TIPS

Without TIPS

Description:

Prospective cohort that did not receive TIPS